flanders.bio provides you with insights in the vibrant life sciences sector

 

News from flanders.bio and its members

TiGenix to present positive 52-week Phase III Cx601 data at EHA-SWG Scientific Meeting

TiGenix NV (Euronext Brussels and NASDAQ: TIG), an advanced biopharmaceutical company focused on exploiting the anti-inflammatory properties of allogeneic, or donor-derived, stem cells to develop novel therapies for serious medical conditions, today announces that the positive 52-week results from its ADMIRE-CD Phase III clinical trial of Cx601 for the treatment of complex perianal fistulas in patients with Crohn's disease will be presented at the EHA-SWG Scientific Meeting on Shaping the Future of Mesenchymal Stromal Cells Therapy taking place from November 23-25, 2017 in Amsterdam, Netherlands. TiGenix is a contributor of the meeting.

Research | 21 November 17
Read more
20
Nov
2017

MDxhealth teams up with Pharmaceutical Company Ferrer for distribution of its Prostate Cancer test SelectMDx in Spain

MDxHealth SA (Euronext: MDXH.BR), a world leader in molecular diagnostic prostate cancer testing, today announced the appointment of Ferrer as exclusive distributor for Spain of its SelectMDx® for prostate cancer as from January 2018. Ferrer is, an international privately-held pharmaceutical company, headquartered in Barcelona, Spain, and with operations in over 95 countries.

20
Nov
2017

ALBATROSS with GLPG2222 shows positive clinical results in CF patients

Galapagos NV (Euronext & NASDAQ: GLPG) reports positive topline results from its ALBATROSS Phase 2 study in cystic fibrosis patients with C1 corrector GLPG2222.

20
Nov
2017

Genohm: ISO 9001:2015 Certification - It’s a Big Deal

Virtually every corner of our life is touched by ISO standards. What began as a method for standardizing weights and measures has evolved into both a philosophy and a series of processes that maintain quality in just about everything we encounter on a day to day basis. Our health and safety, the food we eat, the cars we drive, the toys our children play with, the medical devices at the local hospital, the environment around us — they are all impacted in one way or another by the governing principle behind ISO: maintaining the reliability and efficiency of products and services in our lives.

17
Nov
2017

Imec en partners ontwikkelen Internet-of-Things systeem met sensor-en robottechnologie die gepersonaliseerde interactie met zorgbehoevende ouderen mogelijk maakt

Imec, ’s werelds toonaangevende onderzoeks- en innovatiehub op het vlak van nano-elektronica en digitale technologie, staat mee aan de wieg van de eerste zorgrobot die gericht en persoonlijk kan interageren met rusthuisbewoners. De zorgrobot wordt vandaag gedemonstreerd bij de voorstelling van de resultaten van het imec.icon-project WONDER, een samenwerking tussen imec, de bedrijven Zora Robotics en Xetal en de woonzorgcentra WZC De Vijvers en WZC Weverbos.

20
Nov
2017

MDxhealth teams up with Pharmaceutical Company Ferrer for distribution of its Prostate Cancer test SelectMDx in Spain

MDxHealth SA (Euronext: MDXH.BR), a world leader in molecular diagnostic prostate cancer testing, today announced the appointment of Ferrer as exclusive distributor for Spain of its SelectMDx® for prostate cancer as from January 2018. Ferrer is, an international privately-held pharmaceutical company, headquartered in Barcelona, Spain, and with operations in over 95 countries.

20
Nov
2017

ALBATROSS with GLPG2222 shows positive clinical results in CF patients

Galapagos NV (Euronext & NASDAQ: GLPG) reports positive topline results from its ALBATROSS Phase 2 study in cystic fibrosis patients with C1 corrector GLPG2222.

20
Nov
2017

Genohm: ISO 9001:2015 Certification - It’s a Big Deal

Virtually every corner of our life is touched by ISO standards. What began as a method for standardizing weights and measures has evolved into both a philosophy and a series of processes that maintain quality in just about everything we encounter on a day to day basis. Our health and safety, the food we eat, the cars we drive, the toys our children play with, the medical devices at the local hospital, the environment around us — they are all impacted in one way or another by the governing principle behind ISO: maintaining the reliability and efficiency of products and services in our lives.

17
Nov
2017

Imec en partners ontwikkelen Internet-of-Things systeem met sensor-en robottechnologie die gepersonaliseerde interactie met zorgbehoevende ouderen mogelijk maakt

Imec, ’s werelds toonaangevende onderzoeks- en innovatiehub op het vlak van nano-elektronica en digitale technologie, staat mee aan de wieg van de eerste zorgrobot die gericht en persoonlijk kan interageren met rusthuisbewoners. De zorgrobot wordt vandaag gedemonstreerd bij de voorstelling van de resultaten van het imec.icon-project WONDER, een samenwerking tussen imec, de bedrijven Zora Robotics en Xetal en de woonzorgcentra WZC De Vijvers en WZC Weverbos.

Facts & Figures

CONSULT OUR LIFE SCIENCE DATABASE

 

Innovation is at the core of the life sciences sector and Belgium has a track record of developing ingenious ways to improve the quality of life of millions of people worldwide.

 

Not only extensive life sciences facilities support this high-level technology industry but also financial benefits for R&D companies, international collaborations that guarantee regular cash flow, world known educational systems, a promising product pipeline, and Belgium’s unique central location in Europe.

 

Belgium concentrates on a small territory (30,528 km2) more than 300 life sciences companies with biotech activities. In total, the life sciences sector employs more than 30,000 people (low bound estimation that does not take into account indirect employment generated by the sector). The majority of the companies is related to healthcare, but Belgium also has a strong representation of agricultural and industrial biotech companies.

 

The growing life sciences sector gathers 8 main Belgian universities, 19 research parks and 23 incubators, research institutes, academic hospitals, and clinical research organizations. Biotech companies have access to more than 500,000 square feet of highly flexible infrastructure.

 

Additional assets of Belgium includes: a supportive regulatory and political environment, a highly qualified and productive workforce, a competitive tax environment especially for research companies, a prominent location and an excellent logistical and business infrastructure.

Z Life Sciences

A look behind the scenes of the vibrant life sciences sector in Flanders, Belgium in 11 episodes.

1

VIB

VIB is a life sciences research institute based in Flanders. With more than 1470 scientists from over 60 countries, they perform basic research into the molecular foundations of life and they translate this research into pharmaceutical, agricultural and industrial applications.

2

imec

imec performs world-leading research in nano-electronics and creates groundbreaking innovation in application domains such as healthcare, smart cities and mobility, logistics and manufacturing, and energy. The combination of their widely acclaimed leadership in microchip technology and profound software and ICT expertise is what makes imec unique.

3

Bio Base Europe Pilot Plant

Bio Base Europe Pilot Plant is an independent, state-of-the-art facility that operates from a laboratory level to a multi-ton scale. Bio Base Europe Pilot Plant provides process development, scale-up and custom manufacturing of biobased products and processes. 

 

E-letter archive

Interested in a regular update of the Life Sciences and biotech sector in Flanders?